430 related articles for article (PubMed ID: 37997517)
1. Chemotherapy in pediatric brain tumor and the challenge of the blood-brain barrier.
Malik JR; Podany AT; Khan P; Shaffer CL; Siddiqui JA; Baranowska-Kortylewicz J; Le J; Fletcher CV; Ether SA; Avedissian SN
Cancer Med; 2023 Dec; 12(23):21075-21096. PubMed ID: 37997517
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review).
van Vulpen M; Kal HB; Taphoorn MJ; El-Sharouni SY
Oncol Rep; 2002; 9(4):683-8. PubMed ID: 12066192
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients.
Guntner AS; Peyrl A; Mayr L; Englinger B; Berger W; Slavc I; Buchberger W; Gojo J
Acta Neuropathol Commun; 2020 Jun; 8(1):78. PubMed ID: 32493453
[TBL] [Abstract][Full Text] [Related]
6. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
8. Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier.
On NH; Miller DW
Curr Pharm Des; 2014; 20(10):1499-509. PubMed ID: 23789953
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.
Dréan A; Goldwirt L; Verreault M; Canney M; Schmitt C; Guehennec J; Delattre JY; Carpentier A; Idbaih A
Expert Rev Neurother; 2016 Nov; 16(11):1285-1300. PubMed ID: 27310463
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.
Wu L; Li X; Janagam DR; Lowe TL
Pharm Res; 2014 Mar; 31(3):531-40. PubMed ID: 23996470
[TBL] [Abstract][Full Text] [Related]
11. A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.
Stewart DJ
J Neurooncol; 1994; 20(2):121-39. PubMed ID: 7807190
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
[TBL] [Abstract][Full Text] [Related]
13. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance.
Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C
Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
Verma V; Simone CB; Mishra MV
J Natl Cancer Inst; 2018 Apr; 110(4):. PubMed ID: 29028221
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
[TBL] [Abstract][Full Text] [Related]
16. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic chemotherapy: advances in delivery, pharmacology, and testing.
Ciordia R; Supko J; Gatineau M; Batchelor T
Curr Oncol Rep; 2000 Sep; 2(5):445-53. PubMed ID: 11122877
[TBL] [Abstract][Full Text] [Related]
18. Influence of radiation on the blood-brain barrier and optimum time of chemotherapy.
Qin DX; Zheng R; Tang J; Li JX; Hu YH
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1507-10. PubMed ID: 2262373
[TBL] [Abstract][Full Text] [Related]
19. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.
Verma V; Mishra MV; Mehta MP
Cancer; 2016 May; 122(10):1483-501. PubMed ID: 26828647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
